WHOCC
Postal address:
WHO Collaborating Centre for Drug Statistics Methodology
Norwegian Institute of Public Health
Postboks 222 Sk°yen
0213 Oslo
Norway

Visiting/delivery address:
Myrens verksted 6H
0473 Oslo
Norway

Tel:  +47 21 07 81 60
E-mail:
 
Copyright/Disclaimer

New DDDs

ATC codeATC level name New DDD
B02BX09 fostamatinib 0.2gO
B03XA05roxadustat43mgO
B06AC06berotralstat0.15gO
C01DX22 vericiguat10mgO
C10AX15bempedoic acid0.18gO
C10AX16 inclisiran1.6mgP
C10AX18volanesorsen20mgP
D11AH07tralokinumab16.1mgP
D11AH08 abrocitinib0.15gO
G01AF21tinidazole0.2gV
J01GB06amikacin0.59gInhal.solution
J05AB18molnupiravir1.6gO
J05AE30nirmatrelvir and ritonavir0.6 1)gO
J06BD05sotrovimab0.5gP
L04AA45filgotinib0.2gO
L04AA50 ponesimod20mgO
L04AA52ofatumumab 0.67mgP
L04AA59avacopan60mgO
L04AC21bimekizumab5.7mgP
L04AX09 diroximel fumarate0.924gO
M05BX05 burosumab2.5mgP
M05BX06 romosozumab 7mgP
M09AX10risdiplam5mgO
N02CD06rimegepant37.5mgO
N03AX26fenfluramine 8mgO
N07BC01buprenorphine1.6mgimplant
N07XX15inotersen41mgP
P01CX04miltefosine0.15gO
1) refers to nirmatrelvir

Last updated: 2022-11-25